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increased in response to treatment. EMF treatment markedly 
increases the number of cells immunopositive to TGF~. 
Conclusions: Treatment with EMF appears to be disease 
modifying in this model of osteoarthritis. Since TGF~ is believed 
to upregulate gene expression for aggrecan, downregulate matrix 
metalloprotease and IL-1 activity, and upregulate inhibitors of 
matrix metalloprotease (TIMP), the stimulation of TGF~ may be a 
mechanism through which EMF favorably affects cartilage 
homeostasis. 
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THE EFFECT OF ZlNTONA EC (A GINGER EXTRACT) ON 
SYMPTOMATIC GONARTHRITIS 
I. Wialer. D. Caspi, I Grotto, M Yaron 
Department of Reumatology, Ichilov Hospital, TeI-Aviv, Israel 
Aim: Evaluation of the effect of a Ginger extract (Zintona EC) on 
gonarthritis. 
Methods: 20 patients ( 4 men and 16 women) with symptomatic 
gonarthritis (ACR criteria) aged 43-82 years were included after 
randomisation in a double-blind placebo-controlled cross-over 
study of 6 months duration. The treatment group was given a 
Ginger Extract (250 mg of Zingiberis Rhizoma per capsule, qid), 
while the placebo group received the same number of identical 
looking capsules per day The cross-over occurred after 3 months 
of therapy. Results were evaluated by a 100ram visual analog 
scale (VAS) of pain in movement and of handicap. 
Results: Twelve patients completed the entire study period 
while 7 patients dropped out due to inefficacy (4 and 3 while on 
placebo and Zintona respectively) and one patient dropped out 
because of heartburn (while on Zintona). During the first 3 months 
of the trial, mean VAS of pain decreased from 77.5 to 46.5 
(p<0.028) and from 82.1 to41.8 (p<0.006) in both the Zintona and 
placebo arms respectively. After cross-over patients allocated 
from placebo to Zintona further decreased their VAS to 12.3 
(p<0.01) whereas in patients reallocated to placebo, VAS returned 
to its baseline mean level. VAS of handicap was very similar. 
Conclusions: Zintona was as effective as placebo during the first 
3 months study but after cross-over at the end of 6 months study 
the Ginger group showed a significant superiority over the 
placebo group (p<0.001). 
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EFFICIENCY OF PREPARATION ALPHLUTOP FOR 
OSTEOARTHRITIS 
D Kartvelishvili, R. Akhviediani, L. Shaiamberidze, 1.Gvlchia 
The Science and Practise Center OfReumatology, 
St Andronicashvili, Tblisi 
Aim: The aim of this study was to determine the efficiency 
and sustainability of preparation Alphlutop (produced by 
"Biotechnos", Romania) for treatment of osteoarthritis (OA). 
Methods: Open clinical testing of the preparation was carried out 
on 44 patients. The majority of tested were women (95.8 %) of 
average age 52.8±2.7 years with a positive diagnosis of OA of 
knee and/or hip joints, basically at the II radiological stage and 
with the I degree of functional deficiency of joints. The patients of 
group I (with OA without reactive synovitis n = 20) received intra- 
muscular injections of Alphlutop 1 ml per day (for 21 days). The 
patients of group II (with OA of knee joints with reactive synovitis; 
n= 24) received primarily intra-articular injections of Alphlutop 
twice a week (total 6 injections), then intramuscular injections 
1 ml per day (during 21 days). 
Results: The preparation has had a positively favorable ffect on 
all the parameters: it decreased intensity of pain during move- 
ment, starting point, while moving and at rest, lessened the 
period of covering 50 meters and decreased defiguration of knee 
joints. Evaluation of the obtained results showed a favorable 
effect in 80.0 % of cases in group I and in 77.5 % of cases in 
group II. Nevertheless, a larger gradient of major improvement 
was registered in group II than in group I (20.8 % and 10.0% 
correspondingly). In 6.8 % of cases side-effects were noticed 
(rashes, itchiness, increased swelling of joints). 
Conclusions: Based on the conducted research a deduction can 
be drawn on the combination of a high therapeutic effect and 
good sustainabitity of preparation Atphlutop. 
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THE ROLE OF THE PERIOSTEAL FLAP IN THE 
CHONDROCYTE TRANSPLANTATION 
K Kajitani, M Ochi, Y Uchio, K Kawasaki, S Maniwa, 
S Furukawa 
The Department of Orthopaedics, Shimane Medical Universi~ 
tzumo, Japan 
Aim: The aim of this study was to determine the role of a 
periosteal flap in chondrocyte transplantation for the treatment of 
an articular cartilage defect. 
Methods: A cartilage defect was created on the patellar groove 
of the rabbit knee. The defect was filled with chondrocytes cul- 
tured in collagen gel, and was covered with a periosteal flap 
whose cambium layer was facing the patella (P group), or facing 
down against the bone marrow (M group). The same defect was 
covered with a periosteal flap which was frozen and thawed three 
times (F group), and an artificial collagen film (C group). 
Results: At 3 and 6 months, the defects were filled with repara- 
tive tissues that showed a smooth surface and resembled hyaline 
cartilage in the P, M and F groups. There were no significant 
differences between the reparative tissues in the three groups 
histologically, immunohistochemically, biochemically, and bio- 
mechanically. Although the collagen film fell down into the defect 
and the reparative tissue had a fibrous tissue-like appearance in 
the C group. 
Conclusions: These results showed that the role of the periosteal 
flap does not have a beneficial humoral or cellular effect on the 
formation of reparative tissue, suggesting that the periosteal flap 
might act as only a mechanical barrier to prevent leakage of the 
grafted chondrocytes. 
PB30 
BARRIERS TO APPROPRIATE UTILISATION OF HIP/KNEE 
JOINT REPLACEMENTS 
C Sanders, J Donovan, J Chard, P Dieppe 
MRC HSRC, Bristol, UK 
Introduction: While total joint replacement (TJR) is an effective 
treatment for severe joint disease, research evidence consist- 
ently shows variation in provision and thus potential for unmet 
need. We investigated barriers to appropriate utilization of TJR. 
Methods: Published literature from standard electronic data- 
bases concerned with treatments for osteoarthritis was reviewed. 
Focus group discussions were held with primary care physicians, 
rheumatologists and orthopaedic surgeons to explore their views 
about barriers to utilization. In-depth interviews were undertaken 
with individuals with severe hip/knee disease and low levels of 
service utilization selected from a community prevalence survey 
(Somerset and Avon Survey of Health) to explore why they had 
not sought help. Focus groups and interviews were audio- 
taped and transcribed. Analysis was according to the method of 
constant comparison. 
Results: Evidence of inequality in the provision of TJR was found 
in the literature, with wide variations in surgical rates nationally 
and internationally. Focus group discussions and literature identi- 
fied three potential barriers to appropriate utilization: people with 
joint disease not presenting to primary care physicians, primary 
care physicians not referring people to specialists, and surgeons 
refusing to operate on particular groups (e.g. young, obese). 
Recurring themes in interviews to explain why people did not 
seek health care included perceptions that they were too old or 
unwell for T JR, a view that joint problems were a normal part of 
aging, not wishing to undergo surgery, poor T JR outcomes in 
friends/relatives, and unwillingness to initiate reconsideration 
forreferral/surgery after previous refusal. 
Conclusions: There is the potential to develop strategies that 
might reduce inequality and unmet need, including referral and 
review guidelines for primary care physicians. It is also clear that 
there is a need for further research to establish appropriate indi- 
cations for the timing of T JR that incorporate patient preferences 
and clinical factors. 
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PRIORITIES FOR TOTAL KNEE REPLACEMENT 
IN OSTEOARTHRITIS: THE PATIENTS' PERSPECTIVE 
G.M. Woolhead, J.L. Donovan, J.A. Chard, P.A. Dieppe 
MRC Health Services Research Collaboration, 
University of Bristol, UK 
Aim: To explore patients' views on who with OA should have 
priority for total knee replacement (TKR), and to compare their 
views with published criteria. 
Methods: In depth, semi-structured interviews were conducted 
on 25 patients with osteoarthritis (OA) on the waiting list for TKR 
in the UK. The interviews were tape-recorded, transcribed and 
analysed for themes. In addition, a literature search on the 
criteria for joint surgery and its prioritization in OA was under- 
taken. 
Results: All participants were willing to comment on waiting 
times and prioritization for TKR. Two major themes emerged -- 
what they thought should happen and what they thought did 
happen. Patients thought that priority for surgery should be 
based on the length and degree of suffering, pain severity, degree 
of immobility, payment of National Insurance, paid employment, 
caring for dependents and other personal circumstances. In con- 
trast they thought what actually happened depended on age and 
weight, excessive complaining and financial factors (such as 
access to private practice). Many felt that they had been unfairly 
discriminated against on the basis of age (both too young and 
too old) or obesity. The literature review found seven articles on 
criteria/prioritization forTKR, all of which were consensus based 
rather than evidence based, and none of which included the 
patients' perspective. 
Conclusions: Participants agreed with professionals that pain 
and disability should be key criteria on which to prioritize people 
for a TKR. However, they also argued for a fair and open decision- 
making process that included additional factors specific to 
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individual patient's circumstances. Criteria to aid prioritization for 
joint surgery in OA need to accommodate the views of patients as 
well as professionals. 
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BODY WEIGHT CHARACTERISTICS OF PATIENTS 
EXPERIENCING ASEPTIC LOOSENING, PERIPROSTHETIC 
FRACTURES, AND INFECTIONS AFTER TOTAL HIP 
ARTHROPLASTIES 
R. Marks 
JP Allegrante Hospital for Special Surgery, New York, NY, USA 
Aim: The aim of this study was to assess the relationship 
between selected post-surgical outcomes following total hip 
arthroplasty and the body weight characteristics of hip 
osteoarthritis patients. 
Methods: The body mass indices and percentage of ideal body 
weights relative to height of patients undergoing total hip arthro- 
plasty were assessed. The subjects were males and females 
drawn from a sample of 1000 hip osteoarthritis patients between 
the ages of 30-89 years of age who were hospitalized for pur- 
poses of hip replacement surgery or for complications related to 
prior prosthetic surgery of the hip. 
Results: Approximately 18% had experienced complications 
related to prior surgeries, or to current surgeries. High body mass 
indices and percent ideal weights differentiated those with asep- 
tic loosening, periprosthetic fractures, those with no complica- 
tions and those with infected hips (p<0.007). Conversely, those 
experiencing loosening were more likely to be underweight, 
rather than overweight (p < 0.05). 
Conclusions: A reasonable proportion of patients with hip 
osteoarthritis who undergo hip arthroplasty surgery may exper- 
ience various forms of postsurgical complications, despite the 
excellent outcomes experienced by the majority of patients. Hip 
osteoarthritis patients undergoing hip replacement surgery may 
be at heightened risk for post-surgical complications if they are 
either underweight, or they are obese. It is possible that patient 
outcomes after hip replacement surgery, may be improved by 
presurgical interventions which promote optimal dietary practices 
and the attainment of more optimal body weights relative to 
height, where these are clearly subnormal. 
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AUTOLOGOUS IN VITRO CARTILAGE. ENGINEERING, 
CHARACTERIZATION, APPLICATION 
U. Anderer, J. Libera 
co.don® Research Center, Teltow, Germany 
Aim: Our challenge in tissue engineering is the autologous in vitro 
generation of human cartilage for therapeutical pplication and in 
vitro testing. 
Methods: We established a 3-dimensional chondrocyte culture 
system without he addition of exogenous growth factors or scaf- 
folds. The expression of cartilage specific proteins like collagen 
type II, S-100 and glucosaminoglycans were analyzed on frozen 
sections of in vitro engineered cartilage-like tissue using immuno- 
histological and histological (HE-, Safranin-O staining) methods. 
Results: Spheroids of autologous cultured human chondrocytes 
generated a cartilage-like tissue similar to native hyaline cartilage. 
The expression of cartilage specific proteins and matrix compo- 
nents is increasing with extended time in culture. Adding fetal calf 
serum or antibiotics to culture medium resulted in an inhibition 
of the generation or even the destruction of in vitro engineered 
